Evidence map›Paper›PMID 14687255›Full record

ArticleJournal of general internal medicine2003

Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.

Peter A Ubel, Christopher Jepson, David A Asch

Open access · greenAbstract read
In one paragraph

Article in Journal of general internal medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Are hypertensive elderly patients treated differently?Clinical interventions in aging · 2006
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Patient and provider perceptions of hypertension treatment: do they agree?Journal of clinical hypertension (Greenwich, Conn.) · 2007
    Article
  9. Article
  10. The continuing evolution of women's health.Journal of general internal medicine · 2004
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Peter A UbelVA Health Services Research & Development Center of Excellence, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA. paubel@umich.edu
Christopher Jepson
David A Asch
University of Pennsylvania · USVA Ann Arbor Healthcare System · USVeterans Health Administration · US

Funding

TRADE-OFFS IN CANCER SCREENING, DIAGNOSIS AND TREATMENTR01CA078052 · NCI · UNIVERSITY OF PENNSYLVANIA · PI UBEL, PETER A · 1998 to 1999
–
NCI NIH HHS R01-CA78052-01
6 · The paper itself

Abstract

backgroundBased on a series of clinical trials showing no difference in the effectiveness or tolerability of most major classes of antihypertensive medications, the Joint National Commission on High Blood Pressure Treatment recommends that physicians prescribe beta-blockers or diuretics as initial hypertensive therapy unless there are compelling indications for another type of medication. Nevertheless, many physicians continue to favor more expensive medications like angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers as first line agents. The persistent use of these agents raises questions as to whether physicians perceive ACE inhibitors and calcium channel blockers to be better than beta-blockers and diuretics.

methodsWe surveyed 1,200 primary care physicians in 1997, and another 500 primary care physicians in 2000, and asked them to estimate the relative effectiveness and side effects of 4 classes of medication in treating a hypothetical patient with uncomplicated hypertension: ACE inhibitors, beta-blockers, calcium channel blockers, and diuretics. In addition, we asked them to indicate whether they ever provided free samples of hypertension medications to their patients.

resultsPerceptions of the relative effectiveness and side effects of the 4 classes of hypertension medications did not significantly change over the 3 years, nor did prescription recommendations. Physicians perceive that diuretics are less effective at lowering blood pressure than the other 3 classes (P <.001). They also perceive that beta-blockers are less tolerated than the other 3 classes (P <.001). In a multivariate model, perceptions of effectiveness and tolerability displayed significant associations with prescription preference independent of background variables. The only other variable to contribute significantly to the model was provision of free medication samples to patients.

conclusionsDespite numerous clinical trials showing no difference in the effectiveness or side-effect profiles of these 4 classes of drugs, most physicians believed that diuretics were less effective and beta-blockers were less tolerated than other medications. Moreover, their prescription practices were associated with their provision of free samples provided by pharmaceutical representatives, even after adjusting for other demographic characteristics. Efforts to increase physicians' prescribing of beta-blockers and diuretics may need to be directed at overcoming misunderstandings about the effectiveness and tolerability of these medicines.

Indexed as

Adrenergic beta-AntagonistsAdultAnalysis of VarianceAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersChi-Square DistributionDiureticsDrug UtilizationFemaleHumansHypertensionMaleMiddle AgedPhysicians, FamilyPractice Patterns, Physicians'Surveys and QuestionnairesAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersDiuretics

Identifiers

PMID14687255
PMCPMC1494961
OpenAlexW1992576840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.